Applied Materials Now Says China Grows This Year And Next. Nine Months Ago It Said The Opposite.

by Karl Lindström · August 14, 2026

Semiconductors & Hardware Reporter, Frontier Tech Wire

Anyone scanning wire copy on Applied Materials (Nasdaq: AMAT) this week could reasonably conclude the company said two opposite things about China. One widely circulated framing has the largest US chip-equipment maker warning of weaker Chinese spending in 2026 on tighter American export curbs. Another has it projecting Chinese revenue growth in 2026 despite those same curbs. Both are defensible readings of the record — but not of the same event, and which one applies to Thursday night's fiscal third-quarter results matters to smaller listed suppliers whose revenue mix is far more Chinese than Applied's.

The decline framing traces to Reuters, which reported on 13 November 2025 that Applied expected chipmaking equipment spending in China to fall in 2026, and quoted chief executive Gary Dickerson on the company's China share of sales having reverted from nearly 40% of revenue in recent years to the mid-20% range. That report covered the fiscal fourth quarter of 2025. What chief financial officer Brice Hill told investors on Thursday, 13 August 2026, in Applied's published prepared remarks, was materially different: "We now expect our China revenue to increase this calendar year led by investments in 28-nanometer foundry-logic where Applied has strong technology differentiation and share." On the call itself Hill added: "Our view of China is that it will grow this year and it will grow next year."

Read in sequence, this is an upgrade cycle rather than a contradiction. In November 2025 management guided to a Chinese decline. On the fiscal second-quarter call in May 2026, as reported by TrendForce, Hill described China as flat to slightly higher over the calendar year, with China at 27% of that quarter's sales. By August the language had moved again, to growth this year and next, anchored on 28-nanometer foundry-logic and the wider ICAPS portfolio. Each headline was accurate the day it was written; only the latest describes current guidance.

The numbers in Applied's own release are worth reading carefully, because the China line does not move the way the rhetoric does. Applied reported fiscal Q3 revenue of $9,115m, up 25% from $7,302m a year earlier, with GAAP earnings of $3.17 a share and non-GAAP earnings of $3.50. GAAP gross margin was 50.3%. Semiconductor Systems contributed $7,040m, Applied Global Services $1,781m and the display and other segment $294m. China accounted for $2,506m, or 28% of the total, against $2,548m and 35% a year earlier. In dollars China went slightly backwards; the seven-point share drop is arithmetic, driven by everything else growing hard around it.

There is a definitional trap here. The 28% in the press release is China as a share of total company revenue. The 26% Hill cited on the call is China as a share of Semiconductor Systems plus Applied Global Services — a narrower denominator excluding display. Neither corrects the other, but they are not interchangeable.

The export-control backdrop has not softened, which is what makes the growth guidance a statement about mix rather than about policy. Applied disclosed on 2 October 2025 that expanded US restrictions on China-based customers would reduce net revenue by roughly $600m in fiscal 2026, and separately by about $110m in the then-current fourth quarter of fiscal 2025, which ended on 26 October 2025. The two figures cover different fiscal periods and are not additive parts of one another. On 11 February 2026 it said it had reached a $252.5m resolution with the US Department of Commerce over customer shipments to China between November 2020 and July 2022, which the company attributed to a misunderstanding of how the regulations applied. Dickerson told Reuters in November 2025 that Applied could no longer supply China's memory and older-generation chipmaking markets under tighter US controls. Growth in the still-licensable mature-node layer and exclusion from those segments are not competing claims.

Applied guided fiscal Q4 revenue to $10.25bn plus or minus $500m, and non-GAAP diluted earnings to $4.02 a share plus or minus $0.20. The market's response was not warm. AMAT shares ended Thursday's regular session at $534.54, down 2.48% from Wednesday's $548.15 close, and were quoted at $506.51 late in Thursday's after-hours session, a further 5.24% lower. The after-hours level is a snapshot rather than a settled price; Friday's open will be the first regular-session mark on the print. One plausible irritant sits in the cash-flow statement: for the nine months to 26 July 2026 Applied generated operating cash flow of $5,568m against $5,130m a year earlier, but free cash flow of $3,580m versus $3,655m — capital spending has moved faster than cash generation.

The cleanest listed read-through on Hill's 28-nanometer line is Axcelis Technologies (Nasdaq: ACLS), whose ion-implantation business is weighted to exactly the mature-node and power-device customers Applied described. In results released on 6 August 2026, Axcelis reported second-quarter revenue of $215.2m, with GAAP diluted earnings of $0.75 a share and non-GAAP diluted earnings of $1.06. GAAP gross margin was 42.4%. On the same day's call management split that revenue into roughly $132m of systems revenue and $83m of CS&I aftermarket revenue; the split is call commentary rather than a press-release line item, and it should not be confused with the $14.7m "services" line on the income statement, which is a narrower measure. David Ryzhik, Axcelis's senior vice president and interim chief financial officer, said: "By geography, revenue in China increased sequentially to 46%, up from 40% in the prior quarter." President and chief executive Russell Low said mature-node applications accounted for approximately 84% of system shipments. Axcelis guided third-quarter revenue to about $230m and raised its full-year 2026 growth expectation to roughly mid-single digits.

The subsystem and contract-manufacturing tier below Axcelis is a much looser proxy. Those firms build to original-equipment-manufacturer order rates across the whole customer base, so their revenue tracks aggregate tool demand — currently dominated by AI-driven leading-edge and advanced-packaging capacity — rather than Chinese mature-node appetite, and several do not disclose a China split at all. Any China read-through attributed to them is inference rather than disclosure.

Friday's session will be the first full trading day to price Applied's print, and the near-term test of whether the China upgrade reads as a genuine mix improvement or as a company talking around a revenue line that has gone sideways in absolute dollars for a year. The medium-term tells are more specific: whether Axcelis's China concentration holds above 40% in subsequent filings, whether Applied's fiscal Q4 China dollars finally grow rather than merely holding share, and whether further rule changes of the kind that produced the $600m hit arrive. None of that is knowable now, and any single quarter's geographic mix is a snapshot rather than a trend.